|
Std ID |
Description (Standard Title) |
|
GB/T 16886.18-2011
|
Biological evaluation of medical devices -- Part 18: Chemical characterization of materials
|
|
GB/T 16886.19-2011
|
Biological evaluation of medical devices -- Part 19: Physio-chemical, morphological and topographical characterization of materials
|
|
GB/T 16886.2-2011
|
Biological evaluation of medical devices -- Part 2: Animal welfare requirements
|
|
GB/T 16294-2010
|
Test method for settling microbe in clean room (zone) of the pharmaceutical industry
|
|
GB/T 16292-2010
|
Test method for airborne particles in clean room (zone) of the pharmaceutical industry
|
|
GB/T 16293-2010
|
Test method for airborne microbe in cleanroom (zone) of the pharmaceutical industry
|
|
GB/T 26340-2010
|
Adjustable rehabilitation training bed
|
|
GB/T 26346-2010
|
Rehabilitation training instrument -- Quadriceps training chair
|
|
GB/T 14710-2009
|
Environmental requirement and test methods for medical electrical equipment
|
|
GB/T 14191.1-2009
|
Prosthetics and orthotics -- Vocabulary -- Part 1: General terms for external limb prostheses and external orthoses
|
|
GB/T 16886.3-2008
|
Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
|
|
GB/T 16175-2008
|
Biological evaluation test methods for medical organic silicon materials
|
|
GB/T 21919-2008
|
Laboratory medicine -- Requirements for reference measurement laboratories
|
|
GB/T 22576-2008
|
Medical laboratories -- Particular requirements for quality and competence
|
|
GB/T 16886.10-2005
|
Biological evaluation of medical devices -- Part 10: Tests for irritation and sensitization
|
|
GB/T 16886.12-2005
|
Biological evaluation of medical devices -- Part 12: Sample preparation and reference materials
|
|
GB/T 16886.17-2005
|
Biological evaluation of medical devices -- Part 17: Establishment of allowable limits for leachable substances
|
|
GB/T 19633-2005
|
Packaging for terminally sterilized medical devices
|
|
GB/T 19702-2005
|
In vitro diagnostic medical devices -- Measurement of quantities in samples of biological origin -- Description of reference materials
|
|
GB/T 19703-2005
|
In vitro diagnostic medical devices -- Measurement of quantities in samples of biological origin -- Description of reference materials
|
|
GB/T 16886.5-2003
|
Biological evaluation of medical devices -- Part 5: Test for in vitro cytotoxicity
|
|
GB/T 16886.14-2003
|
Biological evaluation of medical devices -- Part 14: Identification and quantification of degradation products from ceramics
|
|
GB/T 16886.15-2003
|
Biological evaluation of medical devices -- Part 15: Identification and quantification of degradation products from metals and alloys
|
|
GB/T 16886.16-2003
|
Biological evaluation of medical devices -- Part 16: Toxicokinetic study design for degradation products and leachable
|
|
GB/T 16886.4-2003
|
Biological evaluation of medical devices -- Part 4: Selection of tests for interactions with blood
|
|
GB/T 18987-2003
|
Radiotherapy equipment -- Coordinates, movements and scales
|
|
GB/T 16886.1-2001
|
Biological evaluation of medical devices -- Part 1: Evaluation and testing
|
|
GB/T 16886.13-2001
|
Biological evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices
|
|
GB/T 16886.7-2001
|
Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals
|
|
GB/T 16886.9-2001
|
Biological evaluation of medical devices -- Part 9: Framework for identification and quantification of potential degradation products
|
|
GB/T 16886.10-2000
|
Biological evaluation of medical devices--Part 10: Tests for irritation and sensitization
|
|
GB/T 16886.12-2000
|
Biological evaluation of medical devices--Part 12: Sample preparation and reference materials
|
|
GB/T 16886.2-2000
|
Biological evaluation of medical devices--Part 2: Animal welfare requirements
|
|
GB/T 17857-1999
|
Medical radiology. Terminology (Equipment for radiotherapy, nuclear medicine and radiation dosimetry)
|
|
GB/T 17994-1999
|
Guidelines for the development and use of medical electrical equipment educational materials
|
|
GB/T 17995-1999
|
Guidelines for administrative, medical, and nursing staff concerned with the safe use of medical electrical equipment
|
|
GB/T 16886.11-1997
|
Biological evaluation of medical devices--Part 11: Tests for systemic toxicity
|
|
GB/T 16886.1-1997
|
Biological evaluation of medical devices--Part 1: Guidance on selection of tests
|
|
GB/T 16886.3-1997
|
Biological evaluation of medical devices--Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
|
|
GB/T 16886.5-1997
|
Biological evaluation of medical devices--Part 5: Tests for cytotoxicity: in vitro methods
|
|
GB/T 16886.6-1997
|
Biological evaluation of medical devices. Part 6: Tests for local effects after implantation
|
|
GB/T 14710-1993
|
The environmental requirements and test methods for medical electrical equipment
|
|
GB/T 44828-2024
|
Assay method of glucose oxidase activity
|
|
GB/T 44829-2024
|
Assay method of Pf Ago endonuclease activity
|
|
GB/T 41712-2022
|
Assay method of deoxyribonuclease I activity and impurity
|
|
GB/T 41799-2022
|
Assay method of restriction endonuclease impurity
|
|
GB/T 41906-2022
|
Assay method of superoxide dismutase activity
|
|
GB/T 41907-2022
|
Assay method of enterokinase activity
|
|
GB/T 40174-2021
|
Purity detection method of reagent enzymes
|
|
GB/T 39729-2020
|
General requirements for measurement of cell purity - Flow cytometry
|
|
GB/T 39730-2020
|
General requirements for cell counting - Flow cytometry
|
|
GB/T 36389-2018
|
T4 DNA ligase
|
|
GB/T 36390-2018
|
Reagent enzyme -- Lysozyme
|
|
GB/T 36755-2018
|
BST DNA polymerase
|
|
GB/T 36756-2018
|
General requirements for activity detection of reagent enzymes
|
|
GB/T 36757-2018
|
M-MLV reverse transcriptase
|
|
GB/T 36760-2018
|
Term and classification of reagent enzymes
|
|
GB/T 35541-2017
|
pfu DNA polymerase
|
|
GB/T 35543-2017
|
Ribonuclease A
|
|
GB/T 35539-2017
|
Restriction endonuclease BamH Ⅰ
|
|
GB/T 35540-2017
|
Restriction thrombin
|
|
GB/T 35542-2017
|
Taq DNA polymerase
|
|
GB/T 31773-2015
|
Coding rules for Chinese medicinal formulae and their codes
|
|
GB/T 31774-2015
|
Coding rules for Chinese medicines and their codes
|
|
GB/T 31775-2015
|
Coding rules for Chinese medicines in supply chain management
|
|
GB/T 46209-2025
|
Specification for information description of Chinese materia medica resources
|
|
GB/T 19618-2004
|
Licorice
|
|
GB/T 17356.1-1998
|
Grade and quality standards of products of processed American ginseng
|
|
GB/T 17356.2-1998
|
Grade and quality standards of frozen dry American ginseng (active American ginseng)
|
|
GB/T 17356.3-1998
|
Grade and quality standards of American ginseng chips
|
|
GB/T 17356.4-1998
|
Grade and quality standards of American ginseng chewing chips
|
|
GB/T 17356.5-1998
|
Grade and quality standards of American ginseng tea
|
|
GB/T 15517.1-1995
|
The grade quality standards of mould pressing steamed red ginseng
|
|
GB/T 15517.2-1995
|
The grade quality standards of steamed red ginseng
|
|
GB/T 15517.3-1995
|
The Grade Quality Standards of Dried Raw Ginseng of All Tassels
|
|
GB/T 15517.4-1995
|
The grade quality standards of dried raw ginseng
|
|
GB/T 15517.5-1995
|
The grade quality standards of preserved fresh ginseng
|
|
GB/T 15517.6-1995
|
The grade quality standards of activated ginseng
|
|
GB/T 16751.1-2023
|
Clinic terminology of traditional Chinese medical diagnosis and treatment - Part 1: Diseases
|
|
GB/T 16751.3-2023
|
Clinic terminology of traditional Chinese medical diagnosis and treatment - Part 3: Therapeutic methods
|
|
GB/T 42467.1-2023
|
Clinical terminology of traditional Chinese medicine - Part 1: Internal medicine
|
|
GB/T 42467.2-2023
|
Clinical terminology of traditional Chinese medicine - Part 2: External medicine
|
|
GB/T 42467.3-2023
|
Clinical terminology of traditional Chinese medicine - Part 3: Dermatology
|
|
GB/T 42467.4-2023
|
Clinical terminology of traditional Chinese medicine - Part 4: Proctology
|
|
GB/T 42467.5-2023
|
Clinical terminology of traditional Chinese medicine - Part 5: Orthopaedics and traumatology
|
|
GB/T 42467.6-2023
|
Clinical terminology of traditional Chinese medicine - Part 6: Gynecology
|
|
GB/T 42467.7-2023
|
Clinical terminology of traditional Chinese medicine - Part 7: Pediatrics
|
|
GB/T 42467.8-2023
|
Clinical terminology of traditional Chinese medicine - Part 8: Ophthalmology
|
|
GB/T 42467.9-2023
|
Clinical terminology of traditional Chinese medicine - Part 9: Otorhinolaryngology
|
|
GB/T 15657-2021
|
Classification and codes of diseases and patterns of traditional Chinese medicine
|
|
GB/T 40670-2021
|
Guidelines for establishment and development of traditional Chinese medical thesauri
|
|
GB/T 16751.2-2021
|
Clinic terminology of traditional Chinese medical diagnosis and treatment - Part 2: Syndromes/patterns
|
|
GB/T 40975-2021
|
Pure moxa stick
|
|
GB/T 34406-2017
|
Identification of pearl powder -- Near infrared spectroscopy method
|
|
GB/T 30232-2013
|
General nomenclature of science of acupuncture and moxibustion
|
|
GB/T 30233-2013
|
Indications of acupuncture points
|
|
GB/T 23237-2009
|
Methods of anthropometry for locating acupuncture points
|
|
GB/T 13734-2008
|
Nomenclature and location of auricular points
|
|
GB/T 12346-2006
|
Nomenclature and location of acupuncture points
|
|
GB/T 16751.1-1997
|
Clinic terminology of traditional Chinese medical diagnosis and treatment. Disease
|